NU
Nuo Therapeutics
NURO·OTCReston VAFounded 200010 employees
Micro CapbiotechPublicDermatology
Platform: Wound CurraProx
Market Cap
$0.005B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (NURO)
Loading NURO stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Polasacituzumab | NUR-3170 | Phase 1/2 | 1 | CDK4/6 | IPF | ||
| NUR-9873 | NUR-9873 | Phase 3 | 3 | TROP-2 | Crohn'sAS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)